Phase 2 Cardiovascular Risk Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Reducing Systemic Inflammation in People on Antiretroviral Therapy
Cardiovascular Risk FactorHuman Immunodeficiency Virus (HIV)
Centre hospitalier de l'Université de Montréal (CHUM)150 enrolled1 locationNCT07030920
Recruiting
Phase 2
Lumasiran in Hyperoxalaemic Patients on Haemodialysis
Cardiovascular DiseaseCardiovascular Risk FactorChronic Kidney Disease Requiring Chronic Dialysis+2 more
Charite University, Berlin, Germany50 enrolled1 locationNCT06225544
Active
Phase 2
A randomised double-blind placebo controlled trial of cardiovascular risk reduction during bereavement
Cardiovascular RiskBereavement
Royal North Shore Hospital80 enrolled5 locationsACTRN12618001387213
Not Yet Recruiting
Phase 2
Protein intake metabolic effects study
Bone structure of elderly healthy womenCardiovascular risk factors of elderly healthy womenMuscle mass of elderly healthy women+2 more
A Professor RL Prince220 enrolled1 locationACTRN12607000163404